citrafleet powder for oral solution
laboratorios casen-fleet s.l.u. - sodium picosulfate magnesium oxidum leve citric acid - powder for oral solution
citrafleet powder for oral solution
laboratorios casen-fleet s.l.u. - sodium picosulfate magnesium oxidum leve citric acid - powder for oral solution
fleet phospho-soda 24.4g/10.8g oral solution
laboratorios casen-fleet s.l.u. - sodium phosphate dibasic dodecahydrate sodium phosphate dibasic dihydrate - oral solution - 24.4/10.8 grams
fleet phospho-soda 24.4g/10.8g oral solution 24.4/10.8 grams oral solution
laboratorios casen-fleet s.l.u. - sodium phosphate dibasic dodecahydrate sodium phosphate dibasic dihydrate - oral solution - 24.4/10.8 grams
fleet ready-to-use enema 21.4/9.4 grams rectal solution
laboratorios casen-fleet s.l.u. - sodium dihydrogen phosphate dihydrate disodium phosphate dodecahydrate - rectal solution - 21.4/9.4 grams
fleet ready-to-use enema
laboratorios casen-fleet s.l.u. - sodium dihydrogen phosphate dihydrate disodium phosphate dodecahydrate - rectal solution - 21.4/9.4 grams
peglax 10 grams powder for oral solution
laboratorios casen-fleet s.l.u. - macrogol 4000 - powder for oral solution - 10 grams
citrafleet 10 mg/3.5 g/10.97 g powder for oral solution
getz bros. philippines, inc.; distributor: getz bros. philippines, inc. - sodium picosulfate, magnesium oxide , citric acid - powder for oral solution - 10 mg/3.5 g/10.97 g
citracleen powder for solution
laboratorios casen-fleet, s.l.u. - citric acid; sodium picosulfate; magnesium oxide - powder for solution - 10.97g; 10mg; 3.5g - citric acid 10.97g; sodium picosulfate 10mg; magnesium oxide 3.5g - cathartics and laxatives
terbinafine liconsa 250 milligram tablets
laboratorios liconsa, s.a. - terbinafine - tablets - 250 milligram - antifungals for systemic use - antifungals for systemic use - it is indicated in the treatment of the following skin and nail fungal infections: treatment of tinea corporis, tinea cruris and tinea pedis, when oral therapy is considered appropriate depending on the site, severity or extent of the infection and for the treatment of onychomycosis caused by dermatophytes